These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29977583)

  • 21. Hemodialysis and peritoneal dialysis access related outcomes in the pediatric and adolescent population.
    Arhuidese IJ; Wanogho J; Faateh M; Aji EA; Rideout DA; Malas MB
    J Pediatr Surg; 2020 Jul; 55(7):1392-1399. PubMed ID: 31784099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Center-Effect of Incident Hemodialysis Vascular Access Use: Analysis of a Bi-national Registry.
    Ng S; Pascoe EM; Johnson DW; Hawley CM; Polkinghorne KR; McDonald S; Clayton PA; Rabindranath KS; Roberts MA; Irish AB; Viecelli AK
    Kidney360; 2021 Apr; 2(4):674-683. PubMed ID: 35373038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation.
    Suwabe T; Ubara Y; Oba Y; Mizuno H; Ikuma D; Yamanouchi M; Sekine A; Tanaka K; Hasegawa E; Hoshino J; Sawa N
    Mayo Clin Proc Innov Qual Outcomes; 2023 Feb; 7(1):69-80. PubMed ID: 36712823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of medium-term survival between peritoneal dialysis and haemodialysis in accordance with the initial vascular access.
    García-Cantón C; Rufino-Hernández JM; Vega-Díaz N; Pérez-Borges P; Bosch-Benítez-Parodi E; Saavedra P; García-Gómez C; Marrero-Robayna S; Maceira-Cruz B; Rodríguez-Pérez JC; Checa-Andrés MD
    Nefrologia; 2013; 33(5):629-39. PubMed ID: 24089154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dialysis modality, vascular access and mortality in end-stage kidney disease: A bi-national registry-based cohort study.
    Kasza J; Wolfe R; McDonald SP; Marshall MR; Polkinghorne KR
    Nephrology (Carlton); 2016 Oct; 21(10):878-86. PubMed ID: 26630249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of Simultaneous Peritoneal Dialysis and Arteriovenous Fistula Placement in End-Stage Renal Disease Patients.
    Nezakatgoo N; Ndzengue A; Ramaiah M; Gosmanova EO
    Perit Dial Int; 2017; 37(6):658-661. PubMed ID: 29123006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations.
    Marshall MR; Polkinghorne KR; Kerr PG; Hawley CM; Agar JW; McDonald SP
    Am J Kidney Dis; 2016 Apr; 67(4):617-28. PubMed ID: 26561355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Access for starting kidney replacement therapy: vascular and peritoneal temporal access in pre-dialysis].
    Rodríguez CR; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():105-12. PubMed ID: 19018747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease.
    Li L; Szeto CC; Kwan BC; Chow KM; Leung CB; Kam-Tao Li P
    Am J Kidney Dis; 2011 Jun; 57(6):903-7. PubMed ID: 21458901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia.
    Sanabria M; Muñoz J; Trillos C; Hernández G; Latorre C; Díaz CS; Murad S; Rodríguez K; Rivera A; Amador A; Ardila F; Caicedo A; Camargo D; Díaz A; González J; Leguizamón H; Lopera P; Marín L; Nieto I; Vargas E
    Kidney Int Suppl; 2008 Apr; (108):S165-72. PubMed ID: 18379541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis.
    Boonpheng B; Thongprayoon C; Wijarnpreecha K; Medaura J; Chebib FT; Cheungpasitporn W
    Nephrology (Carlton); 2019 Jun; 24(6):638-646. PubMed ID: 29952039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
    Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
    BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in incident hemodialysis access and mortality.
    Malas MB; Canner JK; Hicks CW; Arhuidese IJ; Zarkowsky DS; Qazi U; Schneider EB; Black JH; Segev DL; Freischlag JA
    JAMA Surg; 2015 May; 150(5):441-8. PubMed ID: 25738981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival advantage of initiating dialysis in elderly and non-elderly incident end-stage kidney disease patients.
    Ch'ng CC; Ong LM; Beh KKM; Md Yusuf WS; Chew TF; Lee ML; Hooi LS; Wong HS; Shah Firdaus Khan S; Ahmad G
    Nephrology (Carlton); 2020 Aug; 25(8):644-651. PubMed ID: 31900988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients.
    Coentrão LA; Araújo CS; Ribeiro CA; Dias CC; Pestana MJ
    Perit Dial Int; 2013; 33(6):662-70. PubMed ID: 23455977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of Integrated Home Dialysis Care: Results From the Canadian Organ Replacement Register.
    Desbiens LC; Tennankore KK; Goupil R; Perl J; Trinh E; Chan CT; Nadeau-Fredette AC
    Am J Kidney Dis; 2024 Jan; 83(1):47-57.e1. PubMed ID: 37657633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal dialysis for autosomal dominant polycystic kidney disease: a retrospective study.
    Xie XS; Xie ZT; Xiang SL; Yan XQ; Zhang XH; Shou ZF; Chen JH
    J Zhejiang Univ Sci B; 2016 May; 17(5):375-81. PubMed ID: 27143265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.
    Portolés J; Moreno F; López-Sánchez P; Mancha J; Gómez M; Corchete E; Del Peso G; Bajo MA; Llópez-Carratalá R; Fernández-Perpén A;
    Nefrologia; 2011; 31(4):441-8. PubMed ID: 21738247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.